Stocks to buy

The biotech sector, under the life sciences umbrella, exited 2023 with 41 bankruptcies. This was not surprising given the disparity between biotech’s high-capital requirements and rising interest rates set by the Fed. Despite these challenges, some of the best biotech stocks show promise and resilience in a volatile market environment. At the same time, smaller
0 Comments
In the last week of May, SaaS stocks faced a reckoning. A revenue miss by Salesforce (NYSE:CRM) triggered one of the sector’s severest selloffs in two years. However, investors have been throwing out the baby with the bath water, creating some attractive SaaS stocks to buy. In hindsight, the selloff in SaaS was slowly brewing
0 Comments
Hyper-growth stocks offer excitement, but their lifespan can be fleeting. Successful growth investors seek durable companies with long-term potential. Innovative firms continually emerge, offering transformative growth opportunities.  Despite misconceptions, the U.S. economy exhibits promise. GDP grows steadily, and unemployment recently hit historic lows near 4% as reduced inflation stabilizes prices, easing financial strain. Wage hikes
0 Comments
As their names suggest, growth stocks offer investors the best hope of outperforming the market. While larger companies are in the market, companies experiencing high growth have products and services people want, which translates to growing revenue, earnings and/or cash flow.  Of course — like everything in life — it’s not always positive. The potential
0 Comments
With the market presenting challenges for investors, the case for trustworthy dividend stocks naturally rises. Providing a mixture of relatively predictable businesses with consistent passive income, these stalwart enterprises offer one of the best ways to stave off market jitters. Plus, it’s possible that monetary policy could end up favoring these income providers. Should the
0 Comments